![]() |
Looking for a CDMO partner for the development and manufacture of your Potent APIs?Demand for Potent APIs is growing strongly, driven by the need for targeted medicines in the oncology field. Potent compounds are characterized by an OEL of 1-10μm/m3/8hrs (Band 3A) and such APIs may require commercial batch sizes from ten to several hundred kgs. Due to their high pharmacological activity and complexity, the development and manufacturing of Potent APIs require facilities with specialized containment, operated by experienced personnel. Discover how Novasep, a reliable CDMO, can help you with the manufacture of your Potent APIs! |
> Our capabilities
> An exclusive case study about the robust process development and large-scale manufacture of Potent APIs for the treatment of cancer, from Phase III to commercial